RESUMO
Introducción: El 80% de los niños con condiciones médicas crónicas complejas presentan alteración de la conducta alimentaria. Dada la heterogeneidad de los diagnósticos y la complejidad en el manejo de la disfagia pediátrica, es muy importante la intervención de equipos especializados. Objetivo: Evaluación de la evolución de los niños con trastornos de la deglución y/o conducta alimentaria atendidos durante el año 2017 por el equipo interdisciplinario de deglución y conducta alimentaria, del Hospital de Pediatría Juan P. Garrahan. Material y métodos: Estudio analítico, prospectivo y longitudinal con la intervención de un equipo interdisciplinario. Se incluyeron todos los pacientes evaluados durante el año 2017. Se realizó evaluación clínica de la deglución que permitió detectar dificultades durante el momento de la alimentación. Se dieron pautas de estimulación y modificación de consistencias y se derivó a tratamiento oportuno. Se midió porcentaje de destete de soporte nutricional (SN) y/o aumento del aporte por vía oral. Resultados: evaluamos 153 pacientes, 39% mujeres, 90% menores de 3 años de edad y el 75% en apoyo nutricional. El 72% presentó trastorno de la deglución exclusivamente o asociado a trastorno de la conducta alimentaria. El 68% fue seguido en más de una oportunidad. El 36% de los pacientes que ingresaron con requerimiento de SN lograron el destete (sin diferencia significativa entre los que tenían o no trastorno deglutorio p=0.85 y los que tenían o no traqueostomía p=0,88) y 40% aumentó el aporte por vía oral dentro del grupo que no logró el destete. Se observó una diferencia estadísticamente significativa en el destete de los pacientes que concurrieron al espacio de la clínica con respecto a los que no(p=0,016) y mayor tiempo de intervención entre quienes lograron el destete y quienes no, 5,2 ± 3,1 vs 3,45 ± 3,1 meses (p=0,0099). Conclusión: Es esencial el trabajo interdisciplinario y especializado en niños con trastornos de la deglución. La intervención del fonoaudiólogo como parte del equipo es fundamental para una detección precoz y correcto abordaje de la disfagia (AU)
Of all children with chronic complex medical conditions, 80% have eating behavior disorders. Given the heterogeneity of the diagnoses and the complexity of the management of dysphagia in children, intervention of a specialized medical team is essential. Objective: Evaluation of the outcome in children with swallowing and/or eating behavior disorders seen during 2017 by the interdisciplinary group of swallowing and eating behavior disorders at Hospital de Pediatría Juan P. Garrahan. Material and methods: An analytical, prospective and longitudinal study with intervention by an interdisciplinary team. All patients evaluated during 2017 were included. Swallowing was clinically assessed to identify eating disorders. Indications were given for stimulation and food consistency and patients were referred for adequate treatment. The rates of weaning from nutritional support (NS) and/or increase of oral food intake were measured. Results: 153 patients were evaluated, 39% were female, 90% younger than 3 years of age, and 75% AN. Overall, 72% had swallowing difficulties only or associated with an eating behavior disorder; 68% was followed on more than one occasion. Thirty-six percent of the patients who were admitted with NS requirement could be weaned (without a significant difference between those who had a swallowing disorder and those who did not p=0.85 and those that did and did not have a tracheostomy p=0.88) and oral food intake increased in 40% of the patients in the group that could not be weaned. A statistically significant difference was found in the weaning of patients who attended the clinic and those who did not (p=0.016) and longer intervention time between those who could be weaned and those who could not, 5.2 ± 3.1 vs 3.45 ± 3.1 months (p=0.0099). Conclusion: Interdisciplinary and specialized care is necessary for children with swallowing disorders. Intervention of a speech therapist as part of the team is fundamental for the early detection and adequate management of dysphagia (AU)
Assuntos
Humanos , Recém-Nascido , Lactente , Pré-Escolar , Criança , Transtornos de Deglutição/diagnóstico , Transtornos de Deglutição/reabilitação , Transtornos de Deglutição/terapia , Transtornos da Alimentação e da Ingestão de Alimentos/terapia , Equipe de Assistência ao Paciente , Estudos Prospectivos , Estudos Longitudinais , Apoio Nutricional/métodosRESUMO
Neonicotinoid seed dressings have caused concern world-wide. We use large field experiments to assess the effects of neonicotinoid-treated crops on three bee species across three countries (Hungary, Germany, and the United Kingdom). Winter-sown oilseed rape was grown commercially with either seed coatings containing neonicotinoids (clothianidin or thiamethoxam) or no seed treatment (control). For honey bees, we found both negative (Hungary and United Kingdom) and positive (Germany) effects during crop flowering. In Hungary, negative effects on honey bees (associated with clothianidin) persisted over winter and resulted in smaller colonies in the following spring (24% declines). In wild bees (Bombus terrestris and Osmia bicornis), reproduction was negatively correlated with neonicotinoid residues. These findings point to neonicotinoids causing a reduced capacity of bee species to establish new populations in the year following exposure.
Assuntos
Abelhas/efeitos dos fármacos , Colapso da Colônia , Neonicotinoides/toxicidade , Praguicidas/toxicidade , Agricultura , Animais , Abelhas/classificação , Alemanha , Hungria , Reino UnidoRESUMO
El periodo post operatorio a la cirugía cardiaca es complejo y la nutrición juega un rol fundamental dentro de los cuidados. Luego de una cirugía que requiere bypass cardiopulmonar, los neonatos experimentan una profunda respuesta metabólica al stress. Si esta respuesta ocurre sin un soporte nutricional adecuado, la malnutrición lleva a la pérdida de masa magra y al deterioro de la función de órganos vitales. Objetivo: Describir el estado nutricional y el aporte nutricional alcanzado en niños menores de 3 meses con cirugía cardiovascular durante la implementación de un programa de soporte nutricional intensivo evaluado al ingreso, al tercer y séptimo día post operatorio. Resultados: Se estudiaron 64 pacientes. Se logró la implementación de nutrición parenteral total (NPT) en todos los pacientes que ingresaron al protocolo y que requirieron nutrición parenteral. El promedio de volumen recibido en este periodo fue de 50 ml/kg/día (rango entre 25 y 80 ml/kg/día).Las evaluaciones al ingreso, a las 72 hs. y a la semana post operatoria mostraron que el 70%, 69%y 62,7% respectivamente de los pacientes no llegaron a las 67 kcal/kg/ día propuestas para la intervención nutricional para nuestro objetivos. Por el contrario se encontró que el aporte energético enteral y parenteral administrado en los 3 tiempos estudiados logró cubrir el 100% de los requerimientos metabólicos en reposo (REE) estimados por las fórmulas de Schofield y WHO con resultados similares sin diferencias significativas entre ambas. Conclusión: a pesar de no haber logrado cumplir con el objetivo nutricional calórico propuesto por nuestra intervención nutricional, el mismo logro cubrir el 100% del REE calculado por fórmulas (AU)
The postoperative period after heart surgery is complex and nutrition has a key role in the care process. After a surgery that requires cardiopulmonary bypass, neonates have a severe metabolic response to stress. If this response occurs without adequate nutritional support, malnourishment leads to loss of lean body mass and deterioration of vital organ function. Aim: To describe the nutritional status and nutritional support achieved in infants under 3 months of age who underwent cardiovascular surgery during the implementation of an intensive nutritional support program evaluated on admission and on the third and seventh day postoperatively. Results: Overall, 64 patients were studied. The implementation of total parenteral nutrition (TPN) was achieved in all patients that were included in the protocol and required parenteral nutrition. Median volume administered in this period was 50 ml/kg/day (range, from 25 and 80 ml/kg/day). Evaluation on admission, at 72 hs. and at 1 week postoperatively showed that 70%, 69%, and 62.7% of the patients, respectively, did not achieve the 67 kcal/kg/day proposed as the aim for the nutritional intervention. Conversely, it was found that enteral and parenteral energy delivery administered in the three time points was able to cover 100% of the resting energy expenditure (REE) calculated by the Schofield and WHO formalas with similar results without significant differences. Conclusion: Although the nutritional caloric aim a proposed by our nutritional intervention could not be reached, it was able to cover 100% of the REE calculated using the formulas (AU)
Assuntos
Humanos , Recém-Nascido , Lactente , Nutrição Enteral , Cardiopatias Congênitas/cirurgia , Unidades de Terapia Intensiva Pediátrica , Necessidades Nutricionais , Apoio Nutricional , Nutrição Parenteral , Cuidados Pós-Operatórios , Estudos ProspectivosRESUMO
Introducción: Los craneofaringiomas son malformaciones histológicamente benignas que se sitúan entre el hipotálamo y la hipófisis, zonas con un rol determinante en la modulación de la saciedad. Aun siendo tumores benignos, presentan una considerable morbilidad. La obesidad está presente hasta en un 52% de los pacientes. Objetivo: evaluar factores de riesgo cardiovascular, composición corporal y gasto energético en pacientes con craneofaringioma, y compararlos con un grupo de obesos multifactoriales. Material y métodos: Se incluyeron todos los pacientes con resección quirúrgica de craneofaringioma, menores de 21 años, en seguimiento en nuestro centro entre mayo 2012 hasta abril 2013 que aceptaron participar por medio del consentimiento informado. Se realizó valoración antropométrica, composición corporal con impedanciometría, gasto energético con calorimetría indirecta y valoración de ingesta energética y de macronutrientes. Se determinó resistencia a la insulina (HOMA-IR) y dislipemia. Se comparó a los pacientes con craneofaringioma con obesidad, con un grupo de pacientes con obesidad multifactorial. Resultados: se estudiaron 39 pacientes. El 59% era obeso y presentó significativamente menor% de masa magra (62.4 vs 67.5 p=0.01) y mayor% de masa grasa (37.5 vs 32.5 p=0.01) comparados con los obesos multifactoriales. No se encontró diferencias en el compromiso metabólico entre los obesos con y sin antecedente de craneofaringioma. Se dividieron los pacientes en tertilos según% de gasto energético para categorizar en gasto bajo vs normal. Se encontró asociación positiva entre% de gasto energético y% de masa magra en obesos multifactoriales (68±1%; en los gasto normal vs 62.6± 1% en los gasto bajo: p 0,04). Sin diferencias dentro de la población de obesos con antecedente de craneofaringioma (62±2.7 en los gasto normal/alto vs 61.2±1.8% en los gasto bajo: p 0,8). El gasto energético basal (REE) fue menor en los pacientes con antecedente de craneofaringioma vs obesos multifactoriales, independientemente de la masa magra, lo que sustenta que existirían otros factores que actuarían disminuyendo el gasto energético. No hubo diferencia con respecto a la ingesta en ambos grupos estudiados. Conclusiones: los pacientes con antecedente de craneofaringioma presentan menor gasto energético no relacionado a la masa magra y similar ingesta energética comparado con obesos multifactoriales. No hubo diferencias en el compromiso metabólico entre los obesos con y sin antecedentes de craneofaringioma (AU)
Introduction: Craniopharyngiomas are histologically benign malformations located between hypothalamus and the pituitary gland, areas that play an important role in satiety modulation. Although the tumors are benign, they may cause significant morbidity. Obesity is found in up to 52% of patients. Aim: To assess cardiovascular risk factors, body composition, and energy expenditure in patients with craniopharyngioma, and to compare them to results in a group of children with multifactorial obesity. Material and methods: All patients who underwent surgical resection of craniopharyngioma, younger than 21 years of age, who were being followed-up at our center between May 2012 and April 2013 who gave their informed consent to participate were enrolled in the study. Anthropometric measurements, body composition with impedanciometer, energy expenditure with indirect calorimetry, and energy and macronutrient intake were evaluated. Insulin resistance (HOMA-IR) and dyslipidemia were determined. Patients with craniopharyngioma associated with obesity were compared to patients with multifactorial obesity. Results: Of 39 patients studied, 59% were obese and a significantly lower percentage of lean mass (62.4 vs 67.5 p=0.01) and a higher percentage of fat mass (37.5 vs 32.5 p=0.01) compared to multifactorial obese subjects. No differences were found in metabolic involvement between obese subjects with and those without a history of craniopharyngioma. Patients were divided into tertiles according to percentage of energy expenditure to categorize low versus normal expenditure. A positive correlation was found between percentage of energy expenditure and lean mass percentage in subjects with multifactorial obesity (68±1%; in those with normal energy expenditure versus 62.6±1% in those with low energy expenditure: p 0.04). No difference was found within the group of obese patients with a history of craniopharyngioma (62±2.7 in those with normal/high expenditure versus 61.2±1.8% in those with low expenditure: p 0.8). Baseline energy expenditure (BEE) was lower in craniopharyngioma patients than in those with multifactorial obesity, regardless of lean mass percentage, supporting the hypothesis that other factors may be involved in the decrease of energy expenditure. There was no difference in the food intake between both groups. Conclusions: Patients with a history of craniopharyngioma had a lower energy expenditure unrelated to lean mass and a similar energy intake compared to subjects with multifactorial obesity. No differences were found in metabolic involvement between obese subject with and those without a history of craniopharyngioma (AU)
Assuntos
Humanos , Pré-Escolar , Criança , Adolescente , Composição Corporal/fisiologia , Craniofaringioma/metabolismo , Ingestão de Energia/fisiologia , Doenças Metabólicas/metabolismo , Obesidade/metabolismo , Neoplasias Hipofisárias/metabolismo , Craniofaringioma/complicações , Estudos Transversais , Doenças Metabólicas/complicações , Obesidade/complicações , Estudos Observacionais como Assunto , Neoplasias Hipofisárias/complicações , Estudos ProspectivosAssuntos
Transplante de Rim/imunologia , Transplante de Fígado/imunologia , Imunologia de Transplantes/imunologia , Transplante Homólogo/imunologia , ELISPOT , Granzimas/metabolismo , Antígenos HLA/imunologia , Antígenos HLA-DR/imunologia , Humanos , Imunocompetência/imunologia , Interferon gama/metabolismo , Leucócitos Mononucleares/imunologia , Leucócitos Mononucleares/metabolismo , Doadores Vivos , Teste de Cultura Mista de Linfócitos , Fatores de TempoRESUMO
In the current study, we evaluated a combination of tacrolimus and mycophenolate mofetil (MMF) as GvHD prophylaxis in 50 patients undergoing truly nonmyeloablative (NM; 90 mg/m(2) fludarabine, 2 Gy TBI) hematopoietic SCT (HSCT) from unrelated donors. Median patient age was 51 years (range, 25-67 years). After a median follow-up of 1123 days (range, 47-2729 days), 20 patients (40%) are alive and free from disease. The probabilities of 1-, 2- and 3-year survival were 57, 47 and 39%, respectively. Patients who achieved a remission before HSCT had a significantly better OS compared with those who had active disease (P=0.01). The incidences of grade II-IV and III-IV acute GvHD (aGvHD) were 54% (n=27) and 16% (n=8). Remarkably, using tacrolimus and MMF, the median onset of aGvHD occurred distinctly late on day +66 (range, 12-119 days). A total of 46 patients were evaluable for chronic GvHD (cGvHD). Out of these, 26 (56%) patients developed cGvHD, with 16 (34%) of them showing limited and 10 (21%) showing extensive disease. We conclude that the combination of tacrolimus and MMF as post transplant immunosuppression for patients receiving NM unrelated donor HSCT permits stable engraftment and effective prophylaxis for acute and cGvHD. In particular, the occurrence of severe early-onset aGvHD was attenuated.
Assuntos
Doença Enxerto-Hospedeiro/prevenção & controle , Transplante de Células-Tronco Hematopoéticas , Imunossupressores/uso terapêutico , Ácido Micofenólico/análogos & derivados , Tacrolimo/administração & dosagem , Adulto , Idoso , Feminino , Doenças Hematológicas/tratamento farmacológico , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Humanos , Masculino , Pessoa de Meia-Idade , Ácido Micofenólico/administração & dosagem , Ácido Micofenólico/uso terapêutico , Tacrolimo/uso terapêutico , Quimeras de Transplante , Condicionamento Pré-Transplante/efeitos adversos , Condicionamento Pré-Transplante/métodos , Transplante Homólogo , Resultado do Tratamento , Vidarabina/análogos & derivados , Vidarabina/uso terapêutico , Irradiação Corporal TotalRESUMO
BACKGROUND: We retrospectively determined whether a 3-day short course of palifermin could reduce the toxicity of high-dose therapy (HDT) and autologous blood stem-cell transplantation (ASCT) in patients with multiple myeloma (MM). PATIENTS AND METHODS: Sixty-seven consecutive patients received 60 mug/kg palifermin for 3 days before HDT with melphalan 200 or 140 mg/m(2) for patients with renal failure (group A). Granulocyte colony-stimulating factor (G-CSF) was applied after ASCT. Data on haematopoietic reconstitution and toxicity were compared with two previously published patient groups from our institution who had received pegfilgrastim but not palifermin (group B, n = 21) and patients who had received neither palifermin nor G-CSF (group C, n = 21). RESULTS: In group A, patients with renal failure had a significantly higher risk for severe mucositis (64% versus 16%, P < 0.002). Patients with normal renal function who received palifermin experienced significantly less days of hospitalisation (P < 0.05) and less need for narcotic analgesia (P < 0.05), parenteral nutrition (P < 0.05) and erythrocyte transfusions (P < 0.05) in comparison with groups B and C. Time to haematopoietic reconstitution was not compromised by the use of palifermin. CONCLUSIONS: In conclusion, a short 3-day course of palifermin may be able to reduce the toxicity of HDT and ASCT in patients with MM. Patients with impaired renal function at the time of HDT need additional strategies to further reduce the incidence of severe mucositis.
Assuntos
Fator 7 de Crescimento de Fibroblastos/uso terapêutico , Mucosite/prevenção & controle , Mieloma Múltiplo/terapia , Recidiva Local de Neoplasia/prevenção & controle , Transplante de Células-Tronco de Sangue Periférico , Adulto , Idoso , Antineoplásicos Alquilantes/administração & dosagem , Feminino , Filgrastim , Seguimentos , Fator Estimulador de Colônias de Granulócitos/administração & dosagem , Humanos , Masculino , Melfalan/administração & dosagem , Pessoa de Meia-Idade , Mucosite/etiologia , Mieloma Múltiplo/patologia , Recidiva Local de Neoplasia/patologia , Estadiamento de Neoplasias , Cuidados Paliativos , Polietilenoglicóis , Proteínas Recombinantes , Estudos Retrospectivos , Taxa de Sobrevida , Transplante Autólogo , Resultado do TratamentoAssuntos
Alphapapillomavirus , Condiloma Acuminado , Fator 7 de Crescimento de Fibroblastos/efeitos adversos , Soropositividade para HIV , Linfoma Difuso de Grandes Células B , Condiloma Acuminado/induzido quimicamente , Condiloma Acuminado/patologia , Condiloma Acuminado/terapia , Condiloma Acuminado/virologia , Fator 7 de Crescimento de Fibroblastos/administração & dosagem , Soropositividade para HIV/complicações , Soropositividade para HIV/patologia , Soropositividade para HIV/terapia , Soropositividade para HIV/virologia , Humanos , Linfoma Difuso de Grandes Células B/complicações , Linfoma Difuso de Grandes Células B/patologia , Linfoma Difuso de Grandes Células B/terapia , Linfoma Difuso de Grandes Células B/virologia , Masculino , Estomatite/prevenção & controleRESUMO
La malnutrición en la población hospitalizada se asocia con aumento de la mortalidad, complicaciones médicas, prolongación de la hospitalización y mayores costos. El objetivo del presente estudio fue conocer la prevalencia de malnutrición aguda y crónica en la población hospitalizada e identificar factores asociados. El estudio fue un corte transversal,, que incluyo a todos los pacientes internados en las salas de cuidados intermedios y moderados durante la semana del 12 al 19 de mayo del 2003. El diagnóstico nutricional se basó en métodos antropométricos, aplicando la clasificación de Waterloo modificada. La evaluación incluyó una encuesta administrada por el mismo médico que realizó la antropometría con datos de filiación y procedencia y con información sobre nivel de educación y actividad laboral de los padres, características de la vivienda , número de habitantes por cuarto, ingresos económicos, beneficios de planes sociales y cobertura social. Resultados: Fueron evaluados 198 pacientes con una edad media de 5,2 años más o menos 5, el 42,5% de los pacientes con compromiso nutricional: 19% malnutridos emaciados, 7,9% acortados y emaciados, 15,6% acortados y sobrepeso u obesidad el 11,7% de la población. De los niños con deficit de peso/talla (total 26,9%), el 12, 3% presentó un deficit leve, el 11,2% moderado y el 3,4% grave. 1 de acuerdo al nivel de ingreso las familias se clasificaron como indigentes (ingreso menor de $ 330 ): 43%; pobres (ingreso menor de $ 724) 37%; y con necesidades básicas satisfechas 20%. No se encontró asociación con variables sociales. Las variables biológicas que se asociaron con mayor frecuencia de malnutrición fueron la edad (p=0,04), la condición de cronocidad (p<0,01), y la duración de la internación mayor de 25 días (p=0.04%). En el subgrupo de pacientes evaluados co menos de 5 días de internados conpatologías agudas la frecuencia de malnutridos emaciados fue de 12,6%, de acortados 18,2, normales 60,6%, sobrepeso 9%.
Assuntos
Lactente , Estado Nutricional , Criança Hospitalizada , Transtornos da Nutrição Infantil , Antropometria , Estudos Transversais , Fatores SocioeconômicosRESUMO
PURPOSE: To determine the frequency of maternal-fetal hemorrhage at or above 1 microliter of maternal whole blood. METHODS: Seventy-three mothers whose red blood cells bore an Rh antigen (Rh D, Rh c, Rh E) that was absent on red blood cells of their newborns were identified and a new cytological method, the Kleihauerimmunogold-silver-staining technique, was applied on the blood of their neonates to detect and quantify maternal red blood cells. Stringent precautions were taken to avoid contaminations of neonatal blood samples by adult red blood cells. RESULTS: Maternal red blood cells were present in 3 newborns, a frequency of 4% (95% Cl: 1-11%), and the estimated volumes of hemorrhage were 0.8, 1.5, and 101 microliters of maternal whole blood. No obstetric factor was clearly associated in this limited study with the occurrence of maternal-fetal hemorrhage. CONCLUSIONS: Mother-to-fetus microtransfusion greater than 1 microliter is infrequent at or near delivery, and it may be observed after an uncomplicated pregnancy and vaginal delivery.